Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
NeoGenomics, Inc.
About NEO
NeoGenomics, Inc. is a cancer diagnostics company specializing in cancer genetics testing and information services. The Company offers comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with diagnostic and predictive testing to help them diagnose and treat cancer. Its services include clinical cancer testing; interpretation and consultative services; molecular and NGS testing; comprehensive technical and professional services offering; clinical trials and research; validation laboratory services, and oncology data solutions. It operates a network of laboratories for full-service sample processing and analysis services throughout the United States and a full-service sample-processing laboratory in Cambridge, United Kingdom. Its testing services include Cytogenetics (karyotype analysis), Fluorescence In-Situ Hybridization (FISH), Flow cytometry, and others.
Find out what a historical investment in NeoGenomics, Inc. would be worth today using our NEO stock calculator.
Market Capitalisation
$1.09B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
1.32M
High today
$8.90
Low today
$8.34
Open price
$8.40
52-week high
$13.74
52-week low
$4.72
Ready to start your investing journey with Stake?
Open an accountHow do I buy NEO shares in Australia?
Buying NEO shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in NeoGenomics, Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in NEO
What is the ticker symbol of NeoGenomics, Inc.?
The ticker symbol for NeoGenomics, Inc. is NEO.
How much is one share of NEO?
One share of NEO is valued at $8.82 as of 21 May 2026.
What is the market capitalisation of NeoGenomics, Inc. NEO?
As of 21 May 2026 NeoGenomics, Inc. has a market cap of $1.09B.
What is the 52-week high for NeoGenomics, Inc. stock?
The NeoGenomics, Inc. 52-week high stock price is $13.74.
What is the 52-week low for NeoGenomics, Inc. stock?
The NeoGenomics, Inc. 52-week low stock price is $4.72.
Can I buy NEO shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy NEO shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in NEO on Stake
- Buy NEO from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of NEO from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
NEO related stocks